Wellcome Trust’s Salesforce CRM Stock Holding History

Wellcome Trust’s Portfolio CRM Stock Details CRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-6,912	Closed	-$394K	–	36
2014 Q1	$394K	Buy	+6,912	New	+$413K	0.01%	32

Other funds holding CRM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Wellcome Trust's CRM Position: Q2 2014 in Review

Wellcome Trust sold out of Salesforce (CRM) in Q2 2014, closing a stake of 6,912 shares — an estimated $394K sold.

Wellcome Trust first reported a position in CRM in Q1 2014 and held it in 1 quarter. The position peaked at $394K in Q1 2014. 544 funds tracked by Wall St. Rank hold CRM as of Q2 2014.

Wellcome Trust reported no remaining Salesforce position as of Q2 2014 after selling out during the quarter.
Wellcome Trust sold 6,912 Salesforce shares in Q2 2014, an estimated $394K.
Wellcome Trust first reported a position in Salesforce in Q1 2014 and held it in 1 quarter.
Wellcome Trust's Salesforce position peaked at $394K in Q1 2014.
544 funds tracked by Wall St. Rank held Salesforce as of Q2 2014.

Based on Wellcome Trust's 13F filing for Q2 2014, filed 23 Jul 2014.